FDA Warns: Tianji True Slim Contains Banned Drug Ingredien

Federal regulators are advising consumers against purchasing or using Tianji True Slim, a supplement found to contain a banned drug ingredient.

According to the U.S. Food & Drug Administration (FDA), Tianji True Slim is promoted and sold for weight loss, digestive system cleansing, improving metabolism and circulation, restoring energy, and eliminating water retention. Tianji True Slim is promoted on www.AmericaQualityHerbs.com, and may be sold in some retail stores.

FDA laboratory analysis confirmed that “Tianji True Slim” contains sibutramine, a controlled substance that was removed from the market in October 2010 for safety reasons. Because of this, Tianji True Slim poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients who have a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. Tianji True Slim may also interact, in life-threatening ways, with other medications.

The FDA advises consumers to stop taking Tianji True Slim immediately and to discard the product. The FDA also advises consumers who have experienced any negative side effects to consult a health care professional as soon as possible.

The FDA also encourages health care professionals and patients to report adverse events or side effects related to the use of Tianji True Slim to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program. Reports may be submitted online at www.fda.gov/MedWatch/report.htm. The form may also be downloaded at http://www.fda.gov/Safety/MedWatch/HowToReport/DownloadForms/default.htm or may be requested, by toll-free telephone, at 1.800.332.1088. Complete and return the form to the address on the form, or submit by fax to 1.800.FDA.0178.

This entry was posted in Pharmaceuticals, Product Recalls, Recalled Drugs. Bookmark the permalink.

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.